Key Highlights
- Pharmaceutical Inspection Machines Market projected to grow from $1.14 billion in 2026 to $1.62 billion by 2031.
- Fully automated inspection machines are expected to record faster growth.
- Asia Pacific region is likely to witness the highest growth rate during the forecast period.
The global pharmaceutical inspection machines market is expected to grow from around $1.14 billion in 2026 to $1.62 billion by 2031, according to a new report from MarketsandMarkets™.
The report projects the market to expand at a compound annual growth rate (CAGR) of 7.2% between 2026 and 2031, driven by increasing pharmaceutical production, growing healthcare demand and stricter quality requirements across the industry.
The company said rising production of medicines, vaccines, biologics and specialty drugs is increasing the need for faster and more reliable inspection systems in pharmaceutical manufacturing.
As production volumes rise, manufacturers are looking for ways to inspect products at scale without compromising quality. Manual inspection methods are becoming more difficult to manage in high-volume environments, creating stronger demand for automated systems.
Automated Inspection Systems Continue to Gain Demand
According to the report, conventional pharmaceutical inspection machines are expected to account for the largest market share in 2026, representing around 93% of the market. At the same time, fully automated inspection machines are projected to record faster growth during the forecast period.
The report noted that inspection systems held the largest market share by component in 2025, supported by wider adoption of automated quality control technologies across pharmaceutical manufacturing facilities.
These systems are increasingly being used to inspect products such as vials, syringes, ampoules and cartridges, helping manufacturers detect defects, contamination, packaging errors and fill-level inconsistencies more efficiently.
MarketsandMarkets said advanced inspection technologies, including machine vision, AI-powered analytics, X-ray systems, sensors and robotics, are helping companies improve speed and accuracy compared to traditional inspection methods.
By end user, pharmaceutical companies accounted for the largest market share in 2025 due to growing investments in automation, smart manufacturing and quality assurance.
Asia Pacific Expected to See Strongest Growth
The Asia Pacific region is expected to record the fastest growth during the forecast period, with countries such as India, China, Japan and South Korea continuing to expand pharmaceutical manufacturing.
The report said rising demand for generic drugs, biologics and injectable medicines, along with increasing healthcare spending and stronger regulatory requirements, is supporting demand for advanced inspection technologies.
Some of the companies operating in the pharmaceutical inspection machines market include Körber AG, Mettler Toledo, Omron Corporation, Cognex Corporation, Stevanato Group, Optel Group and ACG, according to the report.
